Trailing-twelve-month (TTM) revenue is $1.52 Billion with a year-over-year growth of +25.50%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-28 | $347,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-28 | $345,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-23 |
| Q1 FY2026Period ended 2026-03-29 | $371,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-28 | $458,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $1,522,500,000 |
Current P/S: $8,655,923,200 market capitalization ÷ $1,522,500,000 TTM revenue = 5.69x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T20:00:01.000Z. Latest revenue period ended 2026-06-28.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-28): $458.80M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-24T09:45:38.075Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-27 · USD | FY20212021-12-26 · USD | FY20222022-12-25 · USD | FY20232023-12-31 · USD | FY20242024-12-29 · USD | FY20252025-12-28 · USD |
|---|---|---|---|---|---|---|
| Product | $499M | $592M | $573M | $635M | $713M | $878M |
| Service | $249M | $219M | $325M | $403M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-29 · USD | FY20252025-12-28 · USD |
|---|---|---|
| Asia Pacific | $62M | $71M |
| Europe | $50M | $78M |
| Middle East | $73M | $66M |
| Other Countries | $34M | $47M |
| Other North America | $19M | $19M |
| UNITED STATES | $899M |
$1.52B
$1.52 Billion
+25.50%
vs. $1.21B a year ago (TTM)
+13.51%
5 Year compound annual growth rate
1 Year
+25.50%
3 Year
+16.30%
5 Year
+13.51%
10 Year
+8.71%
15 Year
+7.22%
20 Year
+7.41%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.35B | +$210.50M | +18.53% |
| 2024 | $1.14B | +$99.20M | +9.57% |
| 2023 | $1.04B | +$138.80M | +15.45% |
| 2022 | $898.30M | +$86.80M | +10.70% |
| 2021 | $811.50M | +$63.80M | +8.53% |
| 2020 |
TTM Growth
+25.50%
3-Year CAGR
+16.30%
5-Year CAGR
+13.51%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-24T09:45:38.075Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $423M |
| $469M |
| $747.70M |
| +$30.20M |
| +4.21% |
| 2019 | $717.50M | +$99.50M | +16.10% |
| 2018 | $618.00M | ($133.90M) | (17.81%) |
| 2017 | $751.90M | +$83.20M | +12.44% |
| 2016 | $668.70M | +$11.60M | +1.77% |
